Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132639) titled 'A Randomized Controlled Trial of High-Theabrownin Pu-erh Tea Beverage for Glycemic Improvement in Type 2 Diabetes Mellitus' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Sixth People's Hospital
Condition:
Type 2 diabetes mellitus
Intervention:
Intervention group:drink Pu-erh tea beverage
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-07
Target Sample Size: Intervention group:50;Control group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335967
Published by HT Digi...